Surface Oncology Market Cap 2017-2018 | SURF
Surface Oncology market cap history and chart from 2017 to 2018. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. Surface Oncology market cap as of March 25, 2019 is $0.12B.
||Medical Products Manufacturing
Surface Oncology, Inc. is a clinical-stage immuno-oncology company. It develops therapies for the treatment of cancer. The company's product pipeline includes CD47, CD73, SRF231, SRF373, SRF617, SRF388 and SRF231 which are in clinical stage. Surface Oncology is based in Cambridge, Massachusetts.